ENTITY
Cellivery Therapeutics

Cellivery Therapeutics (268600 KS)

5
Analysis
Health Care • South Korea
Cellivery Therapeutics, Inc. operates as a pharmaceutical company. The Company develops and sells proteins drugs and other products, as well as conducts research and development activities. Cellivery Therapeutics markets its products throughout Korea.
more
Exchange Announcement • 21 Feb 2025 19:02

[Revised] Delisting

Exchange Announcement • 21 Feb 2025 19:02

Resumption a trading(상장폐지에 따른 ì •ë¦¬ë§¤ë§¤ 개시)

Exchange Announcement • 09 Jan 2025 15:54

Filing or Application of Lawsuit, etc. (the Corporate Control Contest)(ì§ë¬´ì§‘í–‰ì •ì§€ê°€ì²˜ë¶„ ê²°ì •ì— 대한 ì¦‰ì‹œí•­ê³ )

Exchange Announcement • 30 Dec 2024 13:40

Court Ruling on Lawsuit, etc.(ì§ë¬´ì§‘í–‰ì •ì§€ê°€ì²˜ë¶„)

Exchange Announcement • 30 Dec 2024 13:39

Court Ruling on Lawsuit, etc.(ì§ë¬´ì§‘í–‰ì •ì§€ê°€ì²˜ë¶„)

x